Actieve functies van Eric M. Krauland
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Hoofd Techniek/Wetenschap/O&O | 01-06-2017 | - |
President | 09-05-2022 | - | |
Corporate Officer/Principal | - | 09-05-2022 |
Loopbaan van Eric M. Krauland
Opleiding van Eric M. Krauland
The Johns Hopkins University | Undergraduate Degree |
Massachusetts Institute of Technology | Doctorate Degree |
Statistieken
Internationaal
Verenigde Staten | 4 |
Operationeel
Chief Tech/Sci/R&D Officer | 1 |
Corporate Officer/Principal | 1 |
President | 1 |
Sectoraal
Health Technology | 2 |
Consumer Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 1 |
---|---|
Adimab LLC
Adimab LLC BiotechnologyHealth Technology Adimab LLC provides human therapeutic antibodies. The firm has discovered antibodies for a wide variety of therapeutic targets within many disease areas, including oncology, immunomodulation, inflammation, neuroscience and pain, cardiovascular and metabolic disease and infectious disease. The company was founded in 2007 by Tillman Gerngross, Dane Wittrup and Errik Anderson and is headquartered in Lebanon, NH. | Health Technology |
- Beurs
- Insiders
- Eric M. Krauland
- Ervaring